<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02133729</url>
  </required_header>
  <id_info>
    <org_study_id>2010.649</org_study_id>
    <nct_id>NCT02133729</nct_id>
  </id_info>
  <brief_title>Metabolic Risk Following Gestational Diabetes Mellitus</brief_title>
  <acronym>IMAGE</acronym>
  <official_title>IMAGE (Metabolic Risk During Gestation) : Prospective Study of Women With Gestational Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes (GDM) is defined by abnormal glucose tolerance during gestation. This
      complication occurs in 4-10% and is associated with fetal complications and macrosomia. In
      addition, women with GDM have an increased risk to develop type 2 diabetes after delivery.
      Despite recommendations, it is difficult to follow-up all women with GDM during the
      postpartum period due to high numbers of subjects that exceed usual healthcare resources. It
      is therefore necessary to focus clinical attention toward women at high risk of type 2
      diabetes in order to set adequate preventive strategies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metabolic index value</measure>
    <time_frame>3 months after delivery (+/- 15 days)</time_frame>
    <description>The primary objective relies on Receiver Operating Characteristic (ROC) curves of metabolic index values using peripheral markers during gestation : C-Reactive Protein ultrasensitive (CRPus), malonaldehyde (MDA) and adiponectin (index = (CRP + MDA)/adiponectin) to detect an abnormal glucose tolerance at 3 months (+/- 15 days) after delivery (M3) during a 75g oral glucose tolerance test (T0&gt;110mg/dl and/or T120 &gt;145mg/dl). The rationale for the index relies on lower adiponectin values high CRPus levels and MDA values during insulin resistance chronic inflammatory status and oxidative stress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of abnormal glucose tolerance in women with GDM</measure>
    <time_frame>3 months (+/- 15 days) following delivery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Prevalence of type 2 diabetes in women with GDM.</measure>
    <time_frame>18 months (+/- 2 months) after delivery</time_frame>
    <description>Prevalence of women with fasting blood glucose levels &gt; 126mg/dl at 18 months (+/- 2 months) after delivery.</description>
  </other_outcome>
  <other_outcome>
    <measure>Adiponectin level</measure>
    <time_frame>18 months (+/- 2 months) after delivery</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">255</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Gestational diabete</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling and OGTT</intervention_name>
    <arm_group_label>Gestational diabete</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women aged over 18years old

          -  Women with the criteria of GDM during pregnancy at 21-35 weeks of gestation (one
             situation):

               -  After a 75g Oral Glucose Tolerance Test (OGTT - WHO criteria) with blood glucose
                  (BG) values at T60≥180mg/dl and/or T120≥153mg/dl

               -  An O. Sullivan test following a 100g oral glucose load with at least two
                  pathological values (T60 ≥ 180mg/dl and/or T120 ≥ 155mg/dl and/or T180 ≥
                  140mg/dl)

               -  With a fasting BG value ≥92mg/dl

          -  Women with signed informed consent

        Exclusion Criteria:

          -  Women aged less than 18years old

          -  Women with pregestational type 2 diabetes

          -  Women without signed informed consent

          -  Women who does not read and/or understand french language

          -  Women not affiliated to the health care system

          -  Women with recent infection (&lt;1month) and/or on steroids or anti-inflammatory drugs.

          -  Women with chronic diseases

          -  Women with a disable state

          -  Women with normal glucose tolerance

          -  Women already incorporated in another clinical study that could interfere with the
             present study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Hôpital Femme-Mère-Enfant - Service de gynécologie obstétrique</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand - Hôpital Gabriel Montpied - Service d'endocrinologie</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Givors - Hôpital de Montgelas - Service de médicine 8</name>
      <address>
        <city>Givors</city>
        <zip>69700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble - Clinique d'Endocrinologie Diabétologie Nutrition</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Groupement Hospitalier Sud - Service d'Endocrinologie, Diabète, Nutrition</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Saint Etienne - Hôpital Nord - Service d'endocrinologie, diabètes, nutrition</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupement Hospitalier des Portes du Sud - Service d'Endocrinologie Diabétologie Nutrition</name>
      <address>
        <city>Venissieux</city>
        <zip>69200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2014</study_first_submitted>
  <study_first_submitted_qc>May 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2014</study_first_posted>
  <last_update_submitted>July 24, 2015</last_update_submitted>
  <last_update_submitted_qc>July 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

